Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Letters: Don’t Forget Lyme Disease When Considering Polymyalgia Rheumatica

Alfred Miller, MD and William P. Docken, MD  |  Issue: July 2013  |  July 1, 2013

Dr. Docken states [in “A Tale of Two Inflammations,” March 2013], “The rapid onset of symptoms suggests the possibility of an exposure, particularly to an infectious agent, but the search for evidence of such a pathogen in PMR [polymyalgia rheumatica] has been, to date, unrevealing.”

In fact, numerous reports indicate Lyme disease may present the identical clinical picture as PMR.1,2 Steroid treatment is contraindicated in Lyme disease.3 Furthermore, giant cell arteritis has also been reported in Lyme disease.4,5

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In view of consequences of an incorrect diagnosis and subsequent treatment, it is imperative to rule out Lyme disease when considering a diagnosis of PMR and or giant cell arteritis.

Alfred Miller, MD
San Antonio, Texas

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Docken Weighs In

My article did not cover the differential diagnosis of either PMR or GCA. PMR is, of course, a clinical diagnosis, with no definitive diagnostic test. Thus, when this diagnosis is under consideration, atypical features must be carefully watched for (e.g., fever, rash, asymmetrically distributed musculoskeletal symptoms and signs, etc.). I personally have never seen a polymyalgic presentation of Lyme disease. Lyme disease is on the diagnostic list in a patient from an endemic area presenting with fever and headache, but I do not routinely screen for Lyme antibody in all patients with suspected GCA.

William P. Docken, MD
Senior Physician
Brigham and Women’s Hospital
Assistant Professor of Medicine
Harvard Medical School
Boston

References

  1. Paparone PW. Polymyalgia rheumatica or Lyme disease? How to avoid misdiagnosis in older patients. Postgrad Med. 1995;97:161-164, 167-170.
  2. Schwartzberg M, Weber CA, Musico J. Lyme borreliosis presenting as a polymyalgia rheumatica-like syndrome. Br J Rheumatol. 1995;34:392-393.
  3. Muslmani M, Gilson M, Sudre A, Juvin R, Gaudin P. Lyme disease with hepatitis and cortico­steroids: a case report. Rev Med Interne. 2012;33:339-342.
  4. Träisk F, Andersson M, Svenungsson E. Three cases of neuroborreliosis misdiagnosed as giant cell arteritis. Scand J Rheumatol. 2012;41:158-160.
  5. Pizzarello LD, MacDonald AB, Semlear R, DiLeo F, Berger B. Temporal arteritis associated with Borrelia infection. A case report. J Clin Neuroophthalmol. 1989;9:3-6.

Share: 

Filed under:Conditions Tagged with:ClinicalDiagnosisLyme DiseasePMRPolymyalgia Rheumatica

Related Articles

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

    Polymyalgia Rheumatica: New Tricks for an Old Disease

    January 29, 2024

    Originally posted Feb. 13, 2023; reposted in conjunction with publication of the PMR supplement to the February 2024 issue of The Rheumatologist. PHILADELPHIA—Polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 First described in 1888, PMR has been a recognized rheumatic disease since at least 1957. Diagnosing the…

    Permanent Vision Loss in Late Giant Cell Arteritis

    October 18, 2018

    Lightspring / shutterstock.com Patients with polymyalgia rheumatica (PMR) or peripheral arthritis may require extra vigilance during treatment because of a suspected link to giant cell arteritis (GCA) and, potentially, permanent vision loss. “Development of giant cell arteritis after treating polymyalgia or peripheral arthritis: a retrospective case-control study,” a March 2018 study published in The Journal…

    Updates on Giant Cell Arteritis

    March 19, 2018

    arka38 / SHUTTERSTOCK.COM SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA:…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences